Register entry
Acerus Pharmaceuticals Corporation
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 8
- Countries
- 0
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11419914 | NOCTIVAdesmopressin acetate | use | Jun 2030 |
| 12090190 | NOCTIVAdesmopressin acetate | product | Jun 2030 |
| 9539302 | NOCTIVAdesmopressin acetate | product | Jun 2030 |
| 11090312 | NATESTOtestosterone | use | Mar 2034 |
| 11744838 | NATESTOtestosterone | use | Mar 2034 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Natesto nasal gel | testosterone | gel, metered, nasal | 42667-5511NDA |
Compare
Other companies listing testosterone
- Encube Ethicals Limited5 sites · 77 NDC
- Endo USA, Inc.3 sites · 33 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Bayer de Mexico, S.A. de C.V.1 site · 10 NDC
- Northstar Rx, LLC,0 sites · 456 NDC
- Prasco Laboratories0 sites · 106 NDC
Enquiry
Common questions
- Is Acerus Pharmaceuticals Corporation FDA approved?
- Acerus Pharmaceuticals Corporation holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Acerus Pharmaceuticals Corporation make?
- 1 product is listed under Acerus Pharmaceuticals Corporation in the openFDA NDC Directory, most often as gel, metered. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.